Mesa Laboratories Stock
Mesa Laboratories, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Siddhartha C. Kadia
- Employees
- 717
- Market cap
- $685 M
- IPO
- 29/02/1984
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to…
Mesa Laboratories stock: price history
1D
-4.1%
1W
-3.9%
1M
-2.2%
6M
+18.8%
YTD
+56.0%
1Y
+65.2%
2Y
-8.4%
5Y
-60.5%
10Y
+3.7%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~95% stronger price swings than usual
Mesa Laboratories stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
Mesa Laboratories develops and distributes specialized instruments and consumables for the life sciences sector and quality control. The business model encompasses four core areas: sterilization and disinfection control, clinical genomics with DNA analysis systems, biopharmaceutical development for protein analysis, and calibration solutions for critical parameters in production and medical environments. By combining hardware such as analyzers from MassARRAY or Gyrolab with specific consumables, reagents, and testing services, the company serves highly regulated industries such as pharma and medical devices through a hybrid model combining product sales with recurring revenue streams.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about Mesa Laboratories
Analyst assessment of Mesa Laboratories
PRICE TARGET LOW
US$110.00
CONSENSUS
US$110.00
MEDIAN
US$110.00
PRICE TARGET HIGH
US$110.00
0
STRONG BUY
3
BUY
5
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Hold
As of: 14/08/2026
Mesa Laboratories stock metrics
P/E
142.42
P/B
3.67
EV/EBITDA
18.63
RETURN ON EQUITY
1.5%
NET MARGIN
4.7%
DEBT/EQUITY
0.54
DIVIDEND YIELD
0.5%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
88.4%
FLOAT SHARES
4,945,461
AVG. DAILY VOLUME (30D)
118,393
Insider transactions (SEC)
Capone Mark Christopher
Alltoft Jennifer Sadie
Ladiwala Shiraz Shabanali
Hall Shannon
Tripeny R Tony
Institutional holders
Dividends
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Mesa Laboratories stock
What does Mesa Laboratories do?
Mesa Laboratories, Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Siddhartha C. Kadia, the company employs around 717 people.
The IPO was on 29/02/1984; the stock trades on NASDAQ under the ticker MLAB.
What do analysts say about Mesa Laboratories stock?
8 analysts rate the stock, the consensus is Hold (as of 14/08/2026).
The average price target is US$110.00, ranging from US$110.00 to US$110.00, with a median of US$110.00.
This is an external assessment, not a statement by Market Jury.
When does Mesa Laboratories report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 95% stronger than usual.
Does Mesa Laboratories pay a dividend?
Yes. The last dividend was US$0.16 per share, ex-date 30/11/2026, paid on 15/12/2026.
The dividend yield is 0.5% (as of 30/06/2026).
Which stocks are comparable to Mesa Laboratories?
Comparable stocks include STERIS, QuidelOrtho, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.
How can I get Mesa Laboratories stock analyzed?
Clicking "Analyze stock" lets five strategies assess Mesa Laboratories against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.